A recent study showed that NPM1 mutations may promote the expression of HOXA5, HOXB5, HOXA10, PBX3, and MEIS1 in AML cells, which was correlated with a worse prognosis in AML (60). Here, HOXA5 is linked to acute myeloid leukemia.